The FY2025 (Dec) proxy of Disc Medicine names 18 peer companies for pay. Among Disc Medicine and these peers, CEO pay was 4th highest of 6 and total shareholder return was 4th highest of 6.
4th highest of 6in Disc Medicine and its pay peers, FY2025 (Dec) by CEO pay:
$8.5M$33.3M
4th highest of 6in Disc Medicine and its pay peers, FY2025 (Dec) by total shareholder return:
$126$487
Pay peer group, FY2025 (Dec) proxy
| Scholar Rock Holding | ||
| Cogent Biosciences | ||
| Protagonist Therapeutics | ||
| IDEAYA Biosciences | ||
| Kymera Therapeutics | ||
| 89Bio, Inc. | Not disclosed | Not disclosed |
| Akero Therapeutics, Inc. | Not disclosed | Not disclosed |
| Centessa Pharmaceuticals plc | Not disclosed | Not disclosed |
| Cullinan Therapeutics, Inc. | Not disclosed | Not disclosed |
| Dyne Therapeutics | Not disclosed | Not disclosed |
| Edgewise Therapeutics | Not disclosed | Not disclosed |
| Fulcrum Therapeutics, Inc. | Not disclosed | Not disclosed |
| Keros Therapeutics, Inc. | Not disclosed | Not disclosed |
| Stoke Therapeutics, Inc. | Not disclosed | Not disclosed |
| Syndax Pharmaceuticals | Not disclosed | Not disclosed |
| Terns Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Viridian Therapeutics, Inc. | Not disclosed | Not disclosed |
| iTeos Therapeutics, Inc. | Not disclosed | Not disclosed |
18 companies
Changes by year
FY2024 (Dec) proxy
- RemovedAstria Therapeutics, Inc.pay peer groupThe six companies marked with an asterisk were added to the 2024 peer group; five companies that no longer met the criteria were removed (Astria Therapeutics, Inc., HilleVax, Inc., Icosavax, Inc., PMV Pharmaceuticals, Inc., and Vor Biopharma, Inc.)
- RemovedHilleVax, Inc.pay peer groupThe six companies marked with an asterisk were added to the 2024 peer group; five companies that no longer met the criteria were removed (Astria Therapeutics, Inc., HilleVax, Inc., Icosavax, Inc., PMV Pharmaceuticals, Inc., and Vor Biopharma, Inc.)
- RemovedIcosavax, Inc.pay peer groupThe six companies marked with an asterisk were added to the 2024 peer group; five companies that no longer met the criteria were removed (Astria Therapeutics, Inc., HilleVax, Inc., Icosavax, Inc., PMV Pharmaceuticals, Inc., and Vor Biopharma, Inc.)
- RemovedPMV Pharmaceuticals, Inc.pay peer groupThe six companies marked with an asterisk were added to the 2024 peer group; five companies that no longer met the criteria were removed (Astria Therapeutics, Inc., HilleVax, Inc., Icosavax, Inc., PMV Pharmaceuticals, Inc., and Vor Biopharma, Inc.)
- RemovedVor Biopharma, Inc.pay peer groupThe six companies marked with an asterisk were added to the 2024 peer group; five companies that no longer met the criteria were removed (Astria Therapeutics, Inc., HilleVax, Inc., Icosavax, Inc., PMV Pharmaceuticals, Inc., and Vor Biopharma, Inc.)
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.